Source comparison
TB-500 for Plantar Fasciitis: Peptide vs Conventional Comparison
TB-500 (2–5mg twice weekly) Upregulates actin synthesis, promotes angiogenesis, increases type I collagen deposition at injury site 3–4 weeks for collagen remodeling markers; 6–8 weeks for structural integrity changes Moderate if mechanical load not adjusted;
This comparison does not assign a generated winner or score.
- TB-500 (2–5mg twice weekly)
- Upregulates actin synthesis, promotes angiogenesis, increases type I collagen deposition at injury site
- 3–4 weeks for collagen remodeling markers; 6–8 weeks for structural integrity changes
- Moderate if mechanical load not adjusted; low if combined with gait modification
- Regenerative effect. Rebuilds tissue structure, not just symptom management
- Corticosteroid injection
- Suppresses inflammatory cytokines (COX-2 inhibition), temporarily reduces pain signaling
- Immediate pain relief (24–72 hours); no structural repair
- High. 60–70% symptom return within 6 months
- Palliative only. Provides temporary relief but accelerates collagen degradation with repeated use
- PRP (platelet-rich plasma)
- Delivers growth factors (PDGF, TGF-beta, IGF-1) to injury site, promotes cellular proliferation
- 4–6 weeks for initial fibroblast response; 12+ weeks for full remodeling
- Low if load management maintained; moderate without concurrent rehab
- Growth factor delivery. Effective but relies on patient's endogenous healing capacity, variable between individuals
- Extracorporeal shockwave therapy (ESWT)
- Mechanical disruption of scar tissue, induces controlled microtrauma to stimulate healing response
- 6–8 weeks for pain reduction; structural changes not consistently measurable
- Moderate. Depends on tissue quality and load management post-treatment
- Mechanical stimulus. Effective for chronic cases but does not directly provide regenerative substrate
- Rest and orthotic management
- Reduces mechanical load on plantar fascia, prevents further microtrauma accumulation
- Symptom reduction in 4–12 weeks if load adequately reduced; no active tissue repair
- High. 50–60% recurrence when activity resumed without gait correction
- Conservative baseline. Necessary but insufficient for structural healing in chronic degenerative cases
- Preceding analysis: TB-500 is the only intervention in this comparison that directly upregulates the structural proteins required for fascial tensile strength. Corticosteroids suppress symptoms but inhibit collagen synthesis. PRP delivers growth factors but depends on the patient's baseline regenerative capacity. ESWT creates a healing stimulus but doesn't provide cellular building blocks. TB-500 does both. It stimulates fibroblast migration and provides the actin-binding scaffold necessary for organized collagen deposition.